• Publications
  • Influence
Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
Background. Clostridium difficile is the leading cause of infectious diarrhea among hospitalized patients and is a major concern for patients undergoing hematopoietic stem cell transplantationExpand
Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience
The epidemiology of invasive mold infections (IMI) in transplant recipients differs based on geography, hosts, preventative strategies, and methods of diagnosis.
Recurrent Clostridium difficile infection: From colonization to cure.
Clostridium difficile infection (CDI) is increasingly prevalent, dangerous and challenging to prevent and manage. Despite intense national and international attention the incidence of primary and ofExpand
Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients
We sought to describe the epidemiology and risk factors for Clostridium difficile infection (CDI) among kidney transplant recipients (KTR) between 1 January 2008 and 31 December 2010.
Increasing incidence of iliopsoas abscesses with MRSA as a predominant pathogen.
OBJECTIVES Iliopsoas abscesses (IPAs) are rare infections involving purulence within the muscles of the iliopsoas compartment, seldom due to Methicillin-resistant Staphylococcus aureus (MRSA)Expand
Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis
Purpose of review To review the most recent data regarding the epidemiology, risks factors, and outcomes among hematopoietic stem cell transplant recipients with Clostridium difficile infectionExpand
Emerging pathogen in immunocompromised hosts: Exophiala dermatitidis mycosis in graft‐versus‐host disease
Infection with the dematiaceous environmental fungus Exophiala, an emerging pathogen in immunocompromised individuals, poses a diagnostic and therapeutic challenge. Herein, we report the firstExpand
Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.
We sought to describe the epidemiology of Clostridium difficile infection (CDI) among adult recipients of autologous hematopoietic stem cell transplantation (auto-HSCT) within the first year afterExpand
Bezlotoxumab: Could This be the Answer for Clostridium difficile Recurrence?
Objective: To review the pharmacology, pharmacokinetics, efficacy, safety, and place in therapy of bezlotoxumab (BEZ), a novel monoclonal antibody against Clostridium difficile toxin B. Data Sources:Expand
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
Importance Control of the global COVID-19 pandemic will require the development and deployment of safe and effective vaccines. Objective To evaluate the immunogenicity of the Ad26.COV2.S vaccineExpand